Biomarkers such as C-terminal agrin fragment-22 (CAF22), brain-derived neurotrophic factor (BDNF), and glial cell line-derived neurotrophic factor (GDNF) have been identified as predictors of sarcopenia and may guide pharmacologic strategies during pulmonary rehabilitation [91]. This evidence concerns the gene GDNF and sarcopenia.